Health
Pfizer expects to cut COVID-19 vaccine production time by close to 50% as production ramps up, efficiencies increase – USA TODAY
As the nation revs up its vaccination programs, the increase could help relieve bottlenecks caused by vaccine shortages.
New research suggests the COVID-19 vaccine made by Pfizer and BioNTech can still work against a mutated coronavirus. Two easier-to-spread new variants of the virus have the world on edge. One was first discovered in Britain and South Africa. (Jan 8)
AP Domestic
Pfizer expects to nearly cut in half the amount of time it takes to produce a batch of COVID-19 vaccine, from 110 days to an average of 60, as it makes the process more efficient and production is built out, the company told USA TODAY.
As…
-
Noosa News23 hours agoWhere, when and why? Everything you need to know about Sunday’s pro-Palestine protest march in Brisbane
-
General19 hours agoIndia to defend ‘red lines’ as fresh tariffs loom
-
General16 hours agoAlbanese government to freeze construction code until 2029, fast-track housing approvals
-
Noosa News22 hours agoDance Nation shows the messy truth of adolescent dance comps